Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.48 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.43 |
| ▸ | PTAFR | P25105 | 1/20 | 0.43 |
| ▸ | HTR1D | P28221 | 1/20 | 0.43 |
| ▸ | HTR2C | P28335 | 1/20 | 0.43 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.43 |
| ▸ | DRD3 | P35462 | 1/20 | 0.43 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 3/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 5/20 | 0.40 |
| ▸ | MEN1 | O00255 | 3/20 | 0.40 |
| ▸ | GMNN | O75496 | 3/20 | 0.40 |
| ▸ | LMNA | P02545 | 3/20 | 0.40 |
| ▸ | BLM | P54132 | 3/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.40 |
| ▸ | TP53 | P04637 | 2/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7950629 | 0.74 | MEN1 (0.31) | SMN1; SMN2MEN1KMT2ACYP1A2 | |
| SCHEMBL1225864 | 0.74 | SMN1; SMN2 (0.53) | SMN1; SMN2ADRA1DPTAFRHTR1DHTR2C | |
| SCHEMBL18894366 | 0.73 | LMNA (0.57) | SMN1; SMN2ADRA1DPTAFRHTR1DHTR2C | |
| SCHEMBL726329 | 0.73 | SMN1; SMN2 (0.48) | SMN1; SMN2ADRA1DPTAFRHTR1DHTR2C | |
| SCHEMBL6437449 | 0.71 | SMN1; SMN2 (0.55) | SMN1; SMN2ADRA1DPTAFRHTR1DHTR2C | |
| SCHEMBL428693 | 0.71 | SMN1; SMN2 (0.52) | SMN1; SMN2ADRA1DPTAFRHTR1DHTR2C | |
| SCHEMBL1260662 | 0.70 | ADRA1D (0.57) | SMN1; SMN2ADRA1DPTAFRHTR1DHTR2C | |
| SCHEMBL28965396 | 0.69 | SMN1; SMN2 (0.73) | SMN1; SMN2ADRA1DPTAFRHTR1DHTR2C | |
| SCHEMBL25578845 | 0.69 | SMN1; SMN2 (0.60) | SMN1; SMN2ADRA1DPTAFRHTR1DHTR2C | |
| SCHEMBL20401677 | 0.69 | SMN1; SMN2 (0.49) | SMN1; SMN2ADRA1DPTAFRHTR1DHTR2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20010026927-A1 | Measuring method and measuring reagent of C-reactive protein | KYOWA MEDEX CO., LTD. (JP) | 2001-10-04 | — | — | US | disclosed |
| EP-1130396-A1 | Measuring method and measuring reagent of C-reactive protein | KYOWA MEDEX CO., LTD. (JP) | 2001-09-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010026927-A1 | Measuring method and measuring reagent of C-reactive protein | PON1, ARG1, PHOSPHO1 | SMN1; SMN2 3886/4885ADRA1D 1591/4885PTAFR 233/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.